Author

Danielle M. Carlson

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA;ORCID 0000-0003-1823-6380Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Akhilesh PandeyiD· 1 shared Amro M. AbdelrahmaniD· 1 shared Brandon WilbanksiD· 1 shared Caitlin ConboyiD· 1 shared Dong-Gi MuniD· 1 shared Enis H. OzmertiD· 1 shared Erik JeseniD· 1 shared Gregory J. GoresiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Akhilesh PandeyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 12, 2026

Transactivation of EGFR by LCK underlies an activity-defined dependency that predicts response to EGFR inhibition in cholangiocarcinoma

Enis H. Ozmert, Jennifer Tomlinson, Ryan D. Watkins…·Rory L. Smoot

The paper identifies LCK-driven EGFR activation as a therapeutic target in cholangiocarcinoma, showing EGFR activity predicts response to EGFR inhibition.

DOI 10.64898/2026.11.11.765714

humanproteomics

𝕏 PostBluesky